- Home
- SSBK vs JSPR Comparison
SSBK vs JSPR Comparison
Compare SSBK & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSBK
- JSPR
- Stock Information
- Founded
- SSBK 2007
- JSPR 2018
- Country
- SSBK United States
- JSPR United States
- Employees
- SSBK N/A
- JSPR N/A
- Industry
- SSBK Commercial Banks
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSBK Finance
- JSPR Health Care
- Exchange
- SSBK Nasdaq
- JSPR Nasdaq
- Market Cap
- SSBK 258.6M
- JSPR 302.0M
- IPO Year
- SSBK 2021
- JSPR N/A
- Fundamental
- Price
- SSBK $37.11
- JSPR $22.05
- Analyst Decision
- SSBK Buy
- JSPR Strong Buy
- Analyst Count
- SSBK 1
- JSPR 10
- Target Price
- SSBK $36.00
- JSPR $74.86
- AVG Volume (30 Days)
- SSBK 24.6K
- JSPR 244.7K
- Earning Date
- SSBK 10-21-2024
- JSPR 11-07-2024
- Dividend Yield
- SSBK 0.97%
- JSPR N/A
- EPS Growth
- SSBK N/A
- JSPR N/A
- EPS
- SSBK 3.52
- JSPR N/A
- Revenue
- SSBK $87,115,000.00
- JSPR N/A
- Revenue This Year
- SSBK N/A
- JSPR N/A
- Revenue Next Year
- SSBK $11.75
- JSPR N/A
- P/E Ratio
- SSBK $10.55
- JSPR N/A
- Revenue Growth
- SSBK 1.89
- JSPR N/A
- 52 Week Low
- SSBK $22.13
- JSPR $4.00
- 52 Week High
- SSBK $37.86
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- SSBK 66.73
- JSPR 54.05
- Support Level
- SSBK $35.21
- JSPR $19.12
- Resistance Level
- SSBK $36.94
- JSPR $21.55
- Average True Range (ATR)
- SSBK 1.36
- JSPR 1.76
- MACD
- SSBK 0.08
- JSPR -0.25
- Stochastic Oscillator
- SSBK 88.21
- JSPR 47.64
About SSBK Southern States Bancshares Inc.
Southern States Bancshares Inc is a full-service community banking institution, that offers an array of deposit, loan, and other banking-related products and services to businesses and individuals in communities. It has three portfolio segments Real estate, Commercial and industrial, Consumer and other.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.